CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Franco Brockelman

OPENALEX: A5025414142↗ORCID: 0000-0002-8876-6179↗

Affiliations

Organizations

Gobierno de Canariasauthorship · ES Hyattsville Community Development Corporationauthorship · US University of New Mexicoauthorship · US

Public evidence

8 connected articles

Cannabis tolerance reduces symptom relief.2025 · Europe PMC Nationally representative surveys on cannabis use lack product details relevant to public health.2023 · PubMed Central Open Access Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars.2023 · Europe PMC Understanding feeling "high" and its role in medical cannabis patient outcomes.2023 · Europe PMC The effectiveness of inhaled Cannabis flower for the treatment of agitation/irritability, anxiety, and common stress.2020 · Europe PMC The Association between Cannabis Product Characteristics and Symptom Relief.2019 · Europe PMC Effectiveness of Raw, Natural Medical <i>Cannabis</i> Flower for Treating Insomnia under Naturalistic Conditions.2018 · Europe PMC Patient-Reported Symptom Relief Following Medical Cannabis Consumption.2018 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Franco Brockelman - Medical Cannabis Research Engine